Last reviewed · How we verify

Clopidogrel 600 mg

Dong-A University · FDA-approved active Small molecule Quality 2/100

Clopidogrel 600 mg is a Small molecule drug developed by Dong-A University. It is currently FDA-approved. Also known as: Plavix 600 mg, Plavix-®.

At a glance

Generic nameClopidogrel 600 mg
Also known asPlavix 600 mg, Plavix-®
SponsorDong-A University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Clopidogrel 600 mg

What is Clopidogrel 600 mg?

Clopidogrel 600 mg is a Small molecule drug developed by Dong-A University.

Who makes Clopidogrel 600 mg?

Clopidogrel 600 mg is developed and marketed by Dong-A University (see full Dong-A University pipeline at /company/dong-a-university).

Is Clopidogrel 600 mg also known as anything else?

Clopidogrel 600 mg is also known as Plavix 600 mg, Plavix-®.

What development phase is Clopidogrel 600 mg in?

Clopidogrel 600 mg is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing